ENTOFOAM 20.8G | Budesonide Rectal Foam for Ulcerative Colitis
ENTOFOAM 20.8G contains Budesonide, a rectal corticosteroid foam used to treat mild to moderate distal ulcerative colitis by reducing inflammation, relieving rectal bleeding, urgency, and discomfort.
ENTOFOAM 20.8G
ENTOFOAM (BUDESONIDE): Comprehensive Guide and Benefits
Introduction to ENTOFOAM (BUDESONIDE)
ENTOFOAM (BUDESONIDE): A Corticosteroid Medication
ENTOFOAM is a prescription rectal corticosteroid foam containing Budesonide. It is primarily indicated for the treatment of mild to moderate active distal ulcerative colitis, including ulcerative proctitis and ulcerative proctosigmoiditis. The foam is administered rectally, delivering the medication directly to the inflamed bowel tissue for targeted anti-inflammatory action.
Budesonide is a locally acting glucocorticosteroid that reduces inflammation by suppressing the release of inflammatory mediators and modulating the immune response within the affected intestinal lining. Due to its high first-pass metabolism, systemic exposure is lower than with many conventional corticosteroids. ENTOFOAM should be used only as prescribed by a qualified healthcare professional.
Key Benefits of ENTOFOAM (BUDESONIDE)
Helps reduce inflammation associated with distal ulcerative colitis.
Relieves rectal bleeding, urgency, and discomfort.
Delivers targeted treatment directly to the affected area.
Provides effective local anti-inflammatory action with reduced systemic exposure.
Supports induction of remission in mild to moderate disease.
How ENTOFOAM (BUDESONIDE) Works
Budesonide binds to intracellular glucocorticoid receptors within the intestinal mucosa, suppressing the production of pro-inflammatory cytokines, prostaglandins, and other inflammatory mediators. This reduces mucosal inflammation, edema, and immune cell infiltration, helping promote healing of the rectal and distal colonic lining while minimizing systemic corticosteroid exposure due to extensive first-pass hepatic metabolism.
Usage Instructions for ENTOFOAM (BUDESONIDE)
Use the rectal foam exactly as prescribed by your healthcare provider.
Shake the canister well before each use if instructed in the product labeling.
Administer using the supplied applicator, preferably after a bowel movement.
Follow the prescribed dosing schedule and complete the full treatment course.
Wash your hands thoroughly after administration and clean or dispose of the applicator as directed.
Medicinal Advantages of ENTOFOAM (BUDESONIDE)
Provides targeted therapy for distal ulcerative colitis.
Reduces rectal inflammation with lower systemic corticosteroid exposure.
Helps improve bowel symptoms and rectal discomfort.
Convenient foam formulation enhances local drug distribution.
May reduce the need for systemic corticosteroid therapy in appropriate patients.
NOTE: ENTOFOAM is a prescription-only medicine. It should be used under the supervision of a gastroenterologist or other qualified healthcare professional. Do not discontinue treatment or alter the prescribed regimen without medical advice.
Off-Label Uses of ENTOFOAM (BUDESONIDE)
Healthcare professionals may occasionally prescribe Budesonide rectal foam for selected inflammatory bowel conditions based on individual clinical judgment.
Adjunctive management of inflammatory rectal disorders.
Selected cases of radiation-induced proctitis.
Supportive treatment in specific inflammatory colorectal conditions.
Disclaimer: Off-label uses should only occur under physician supervision and may not be approved in all countries.
Expert Advice for Optimal Use
Use the foam at the same time each day for consistent treatment.
Follow the administration instructions carefully for optimal drug delivery.
Continue treatment for the full prescribed duration even if symptoms improve.
Attend scheduled follow-up appointments to monitor disease activity.
Inform your healthcare provider about any signs of infection during treatment.
Maintain your recommended ulcerative colitis management plan, including dietary and lifestyle advice.
Precautions
Cardiovascular Health
Systemic absorption is lower than with many oral corticosteroids, but prolonged use may still have systemic effects. Patients with cardiovascular conditions should follow medical advice carefully.
Liver & Kidney Function
Patients with significant liver impairment may have increased systemic exposure to Budesonide. Inform your healthcare provider if you have liver disease. Dose adjustment is generally not required for kidney impairment.
Pregnancy & Breastfeeding
Use during pregnancy or breastfeeding only when clearly needed and after careful evaluation of the benefits and potential risks by a qualified healthcare professional.
Drug Interactions
Strong CYP3A4 inhibitors (such as ketoconazole or clarithromycin) may increase Budesonide exposure. Inform your healthcare provider about all prescription medicines, over-the-counter products, and herbal supplements you use.
Existing Medical Conditions
Use cautiously in patients with active infections, tuberculosis, diabetes, glaucoma, osteoporosis, or other conditions where corticosteroid therapy requires careful monitoring.
Storage Instructions
Store below 25°C or according to the product label.
Keep the container tightly closed when not in use.
Protect from direct sunlight and excessive heat.
Do not puncture or expose the pressurized container to fire.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is ENTOFOAM used for?
A: ENTOFOAM is used to treat mild to moderate active distal ulcerative colitis, including ulcerative proctitis and ulcerative proctosigmoiditis.
Q: What is the active ingredient in ENTOFOAM?
A: ENTOFOAM contains Budesonide, a locally acting corticosteroid.
Q: How is ENTOFOAM administered?
A: It is administered rectally using the supplied applicator exactly as prescribed by your healthcare provider.
Q: Is ENTOFOAM a steroid medicine?
A: Yes. It contains Budesonide, which belongs to the corticosteroid class of anti-inflammatory medicines.
Q: Can I stop using ENTOFOAM when my symptoms improve?
A: No. Complete the full prescribed treatment course unless your healthcare provider instructs otherwise.
Q: Can ENTOFOAM be used for all forms of ulcerative colitis?
A: It is primarily intended for mild to moderate distal ulcerative colitis affecting the rectum and lower colon.
Q: Is ENTOFOAM available without a prescription?
A: No. ENTOFOAM is a prescription-only medication and should be used under medical supervision.
Product Tags
ENTOFOAM, Entofoam 20.8g, Budesonide Rectal Foam, Budesonide, Corticosteroid Foam, Rectal Corticosteroid, Ulcerative Colitis Treatment, Ulcerative Proctitis, Proctosigmoiditis Treatment, Inflammatory Bowel Disease, IBD Medication, Gastroenterology Medicine, Prescription Rectal Foam, Anti-inflammatory Rectal Foam, Distal Ulcerative Colitis, Budesonide Foam, Rectal Inflammation Treatment, Colon Inflammation Therapy, Corticosteroid Medication, Ulcerative Colitis Management
